Studies on the biological balance between thromboxanes and prostacyclins in relation to the platelet-vessel wall interaction.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001241:Aspirin / Q000494:pharmacology; D001760:Bleeding Time; D001792:Blood Platelets / Q000378:metabolism; D001808:Blood Vessels / Q000378:metabolism / Q000502:physiology*; D002648:Child; D003920:Diabetes Mellitus / Q000097:blood; D015118:Eicosapentaenoic Acid; D011464:Epoprostenol / Q000096:biosynthesis / Q000502:physiology*; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D010726:Phosphodiesterase Inhibitors / Q000378:metabolism; D010974:Platelet Aggregation; D011449:Prostaglandin Endoperoxides / Q000378:metabolism; D011453:Prostaglandins / Q000096:biosynthesis / Q000502:physiology*; D013931:Thromboxanes / Q000096:biosynthesis / Q000502:physiology*
D005231:Fatty Acids, Unsaturated; D010726:Phosphodiesterase Inhibitors; D011449:Prostaglandin Endoperoxides; D011453:Prostaglandins; D013931:Thromboxanes; D015118:Eicosapentaenoic Acid; D011464:Epoprostenol; D001241:Aspirin; D006854:Hydrocortisone